€24.90
1.49% today
L&S, Jun 28, 08:04 pm CET
ISIN
US68213N1090
Symbol
OMCL
Sector
Industry

Omnicell, Inc. Share price

$26.27
-6.36 19.49% 1M
-12.08 31.50% 6M
-11.36 30.19% YTD
-42.87 62.00% 1Y
-124.30 82.55% 3Y
-59.96 69.54% 5Y
-2.25 7.89% 10Y
Nasdaq, Closing price Thu, Jun 27 2024
ISIN
US68213N1090
Symbol
OMCL
Sector
Industry

Key figures

Market capitalization $1.21b
Enterprise Value $1.27b
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 7.15
EV/Sales (TTM) EV/Sales 1.15
P/S ratio (TTM) P/S ratio 1.09
P/B ratio (TTM) P/B ratio 1.02
Sales growth (TTM) Sales growth -13.02%
Turnover (TTM) Turnover $1.10b
EBIT (operating result TTM) EBIT $-20.38m
Free cash flow (TTM) Free cash flow $177.99m
Cash position $549.96m
EPS (TTM) EPS $-0.46
P/E ratio expected negative
P/S ratio expected 1.13
EV/Sales expected 1.19
Short interest 6.16%
Show more

Is Omnicell, Inc. a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.

Omnicell, Inc. Share analysis

Unlock scores for free

Analyst opinions

9 Analysts have issued a Omnicell, Inc. forecast:

4x Buy
44%
4x Hold
44%
1x Sell
11%

Analyst opinions

9 Analysts have issued a Omnicell, Inc. forecast:

Buy
44%
Hold
44%
Sell
11%

Financial data from Omnicell, Inc.

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Mar '24
+/-
%
1,103 1,103
13% 13%
100%
- Direct costs 633 633
9% 9%
57%
470 470
18% 18%
43%
- Selling and administrative expenses 231 231
38% 38%
21%
- Research and development costs 93 93
8% 8%
8%
146 146
45% 45%
13%
- Depreciation and amortization 166 166
68% 68%
15%
EBIT (operating result) EBIT -20 -20
1,101% 1,101%
-2%
Net profit -21 -21
20% 20%
-2%

Figures in millions USD.

Don't miss a thing! We will send you all news about the Omnicell, Inc. share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Omnicell, Inc. Share News

Neutral
Business Wire
about 2 months ago
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation.
Neutral
Business Wire
about 2 months ago
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the BofA Securities 2024 Health Care Conference.
Neutral
Seeking Alpha
about 2 months ago
Omnicell, Inc. (NASDAQ:OMCL ) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Kathleen Nemeth – Senior Vice President-Investor Relations Randall Lipps – Founder, Chairman, President and Chief Executive Officer Nchacha Etta – Executive Vice President and Chief Financial Officer Conference Call Participants Stan Berenshteyn – Wells Fargo Matt Hewitt – Craig-Hallum Sco...
More Omnicell, Inc. News

Company profile

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.

Head office United States
CEO Randall Lipps
Employees 3,650
Founded 1992
Website www.omnicell.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now